Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Sierra Oncology Q4 EPS $(1.67) Down From $(1.37) YoY

Sierra Oncology (NASDAQ:SRRA) reported quarterly losses of $(1.67) per share. This is a 21.9 percent decrease over losses of $(1.37) per share from the same period last year.
byBenzinga Newsdesk
March 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Sierra Oncology (NASDAQ:SRRA) reported quarterly losses of $(1.67) per share. This is a 21.9 percent decrease over losses of $(1.37) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts